Development Candidate Information definition

Development Candidate Information will mean a full summary of all material information known to VERTEX about a Development Candidate, which CFFT reasonably needs in order to assess the potential of that Development Candidate as a treatment for CF and to pursue CFFT’s Special Rights under Sections 10.5 and 10.6, if they are applicable. Development Candidate Information will also include comparable information known to VERTEX concerning Compounds which are Back-up Compounds, as defined herein, to the Development Candidate which is the subject of the Development Candidate Information.
Development Candidate Information will mean all material information known to VERTEX about a Development Candidate, including analytical results and raw data, which NOVARTIS reasonably needs in order to decide whether to exercise the Development Election with respect to the Development Candidate. The Development Candidate Information shall include any previously undisclosed information with respect to VERTEX Kinase Technology which is important to a scientific and commercial evaluation of the Development Candidate. Development Candidate Information will also include comparable information known to VERTEX concerning all Compounds which are Back-up Compounds, as defined herein, to the specific Development Candidate which is the subject of the Development Candidate Information. Pursuant to the provisions of Section 5.1 hereof, the Development Candidate Information shall also disclose [***]

Examples of Development Candidate Information in a sentence

  • As soon as Vertex has identified a Development Candidate which it believes meets the Development Candidate Criteria, it will so notify CFFT and the JRC and will include with that notice the Development Candidate Information with respect to that Development Candidate and its Back-up Compounds.

  • As soon as practicable following CombinatoRx’s identification of a Clinical Development Candidate which it believes meets the Clinical Development Candidate Criteria, it will so notify CFFT and the JRC in writing, and will include with that notice the Clinical Development Candidate Information with respect to that Clinical Development Candidate.

  • The Final Report will contain Development Candidate Information for any Compound that VERTEX believes, in the reasonable exercise of its scientific and business judgment, meets the Development Candidate Criteria [***], along with information with respect to relevant Back-up Compounds.

  • The corresponding notice shall be accompanied by the Development Candidate Information relating to the Development Candidate and its Back-up Compounds, provided that information concerning Compound structures shall be handled as specified in Section 5.1 hereof.